What the studies show
No controlled human trial of IGF-1 LR3 exists for muscle, strength or body composition. The claims extrapolate from IGF-1's known role in tissue growth and from animal and cell work.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
In context
IGF-1 LR3 is a modified version of insulin-like growth factor 1, engineered so that it evades the binding proteins that normally control IGF-1 and therefore stays active far longer. It was designed as a cell-culture reagent for laboratories, not as a medicine, and no controlled human trial has ever tested it. Natural IGF-1 is available as an approved drug, mecasermin, for a rare severe deficiency — the LR3 analogue is a different molecule with no clinical file at all.
IGF-1 LR3 is not approved; research reagent. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is IGF-1 LR3 proven to help with muscle growth?
What studies are behind the grade?
Is IGF-1 LR3 approved for this?
Other outcomes for IGF-1 LR3
- DAny clinical outcome0 controlled
- DSafety in humansadverseNone
Written and maintained by LYO Research — how pages are written and checked. Reviewed 3 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →